[go: up one dir, main page]

DK1086216T3 - Pseudo-cykliske oligonukleobaser - Google Patents

Pseudo-cykliske oligonukleobaser

Info

Publication number
DK1086216T3
DK1086216T3 DK00920072T DK00920072T DK1086216T3 DK 1086216 T3 DK1086216 T3 DK 1086216T3 DK 00920072 T DK00920072 T DK 00920072T DK 00920072 T DK00920072 T DK 00920072T DK 1086216 T3 DK1086216 T3 DK 1086216T3
Authority
DK
Denmark
Prior art keywords
pcos
segment
oligonucleotides
pseudo
cyclic
Prior art date
Application number
DK00920072T
Other languages
English (en)
Inventor
Sudhir Agrawal
Ekambar R Kandimalla
Original Assignee
Hybridon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybridon Inc filed Critical Hybridon Inc
Application granted granted Critical
Publication of DK1086216T3 publication Critical patent/DK1086216T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6853Nucleic acid amplification reactions using modified primers or templates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/317Chemical structure of the backbone with an inverted bond, e.g. a cap structure
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/50Physical structure
    • C12N2310/53Physical structure partially self-complementary or closed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Eye Examination Apparatus (AREA)
  • Holo Graphy (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Detergent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Lubricants (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK00920072T 1999-03-31 2000-03-31 Pseudo-cykliske oligonukleobaser DK1086216T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12713899P 1999-03-31 1999-03-31
US17464200P 2000-01-05 2000-01-05
PCT/US2000/008826 WO2000058330A2 (en) 1999-03-31 2000-03-31 Pseudo-cyclic oligonucleobases

Publications (1)

Publication Number Publication Date
DK1086216T3 true DK1086216T3 (da) 2003-08-18

Family

ID=26825372

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00920072T DK1086216T3 (da) 1999-03-31 2000-03-31 Pseudo-cykliske oligonukleobaser

Country Status (9)

Country Link
EP (1) EP1086216B1 (da)
AT (1) ATE241697T1 (da)
AU (1) AU770615B2 (da)
CA (1) CA2334707A1 (da)
DE (1) DE60002967T2 (da)
DK (1) DK1086216T3 (da)
ES (1) ES2197868T3 (da)
PT (1) PT1086216E (da)
WO (1) WO2000058330A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030099959A1 (en) * 1995-04-12 2003-05-29 Kandimalla Ekambar R. Cooperative oligonucleotides
ES2646097T3 (es) * 2009-08-27 2017-12-12 Idera Pharmaceuticals, Inc. Composición para inhibir la expresión de genes y sus usos
WO2012102616A1 (en) * 2011-01-28 2012-08-02 Flexgen B.V. Heterodirectional polynucleotides
WO2023049275A2 (en) * 2021-09-23 2023-03-30 Arnay Sciences, Llc Cyclic structured oligonucleotides as therapeutic agents
WO2024197139A2 (en) * 2023-03-22 2024-09-26 Arnay Sciences, Llc Delivery of rna therapeutics using circular prodrug nucleic acids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399676A (en) * 1989-10-23 1995-03-21 Gilead Sciences Oligonucleotides with inverted polarity
PL172710B1 (pl) * 1992-07-02 1997-11-28 Hybridon Inc Samostabilizujacy sie oligonukleotyd PL PL
AU5741396A (en) * 1995-05-11 1996-11-29 Hybridon, Inc. Pyrimidine targeting hairpin triplex-forming oligonucleotide s
US5866336A (en) * 1996-07-16 1999-02-02 Oncor, Inc. Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon

Also Published As

Publication number Publication date
WO2000058330A2 (en) 2000-10-05
DE60002967D1 (de) 2003-07-03
EP1086216A2 (en) 2001-03-28
DE60002967T2 (de) 2004-05-19
PT1086216E (pt) 2003-09-30
WO2000058330A3 (en) 2001-01-25
AU4066600A (en) 2000-10-16
CA2334707A1 (en) 2000-10-05
AU770615B2 (en) 2004-02-26
ATE241697T1 (de) 2003-06-15
EP1086216B1 (en) 2003-05-28
ES2197868T3 (es) 2004-01-16

Similar Documents

Publication Publication Date Title
Nielsen Peptide nucleic acid. A molecule with two identities
Elayadi et al. Implications of high-affinity hybridization by locked nucleic acid oligomers for inhibition of human telomerase
KR101201664B1 (ko) 신규한 형태의 간섭 rna 분자
RU2006126643A (ru) Олигомерные соединения для модуляции bcl-2
DE60043149D1 (de) -myc zielgerichtete antisenseverbindungen
Bahal et al. Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5
CA2526831A1 (en) Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina)
ATE460481T1 (de) Verfahren zur hemmung der expression eines zielgens und medikament zur therapie einer tumorerkrankung
DE69719220D1 (de) Neue nucleotidanaloga
KR20100063079A (ko) 올리고뉴클레오티드의 탐지 방법
ATE484586T1 (de) Synthetische doppelsträngige oligonucleotide zur gezielten hemmung der genexpression
JP2005517436A5 (da)
Moccia et al. Insights on chiral, backbone modified peptide nucleic acids: properties and biological activity
Rapozzi et al. Antigene effect in K562 cells of a PEG-conjugated triplex-forming oligonucleotide targeted to the bcr/abl oncogene
WO2004078941A3 (en) Modulation of gene expression using dna-rna hybrids
CN108251420A (zh) 抑制人和动物中CTGF基因表达的siRNA、包含其的组合物及其应用
Häner et al. Development of artificial ribonucleases
PT1175489E (pt) Oligonucleotidos contendo uma sequencia antisense estabilizada por uma estrutura secundaria e composicoes farmaceuticas contendo as mesmas
DK1086216T3 (da) Pseudo-cykliske oligonukleobaser
Lee et al. Advantages of the circular dumbbell decoy in gene therapy and studies of gene regulation
HRP20100666T1 (hr) ANTI MIOZINSKA Va siRNA I DEPIGMENTACIJA KOŽE
Pradhan et al. Induced circular dichroism of benzo [a] pyrene-7, 8-dihydrodiol 9, 10-epoxide stereoisomers covalently bound to deoxyribooligonucleotides used to probe equilibrium distribution between groove binding and intercalative adduct conformations
Opalinska et al. Oxetane modified, conformationally constrained, antisense oligodeoxyribonucleotides function efficiently as gene silencing molecules
Reddy et al. Solid-phase synthesis of positively charged deoxynucleic guanidine (DNG) tethering a Hoechst 33258 analogue: triplex and duplex stabilization by simultaneous minor groove binding
Hu et al. Cellular localization and allele-selective inhibition of mutant huntingtin protein by peptide nucleic acid oligomers containing the fluorescent nucleobase [bis-o-(aminoethoxy) phenyl] pyrrolocytosine